UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

6 Dec 2010

Long-term use of antiepileptic drug Vimpat® (lacosamide) effectively reduced partial-onset seizure frequency and improved health-related quality of life

Read More
1 Dec 2010

UCB Amendment to Revolving Credit Facility

Read More
23 Nov 2010

Neupro® (rotigotine) improved motor, sleep and non-motor symptoms of Parkinson’s disease in large-scale study

Read More
9 Nov 2010

Epratuzumab phase IIb data presented at ACR show pipeline drug had positive effect in patients suffering from moderate to severe systemic lupus erythematosus

Read More
9 Nov 2010

New Cimzia (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations with Active Rheumatoid Arthritis (RA)

Read More
21 Oct 2010

Interim Report - Intense growth of Cimzia, Vimpat and Neupro

Read More

Stay up-to-date on the latest news and information from UCB